LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company, today announced that CytRx President and CEO Steven A. Kriegsman and Vice President of Business Development David J. Haen will discuss recent developments, including clinical program updates with its oncology and molecular chaperone drug candidates, during a company presentation at the Lippert/Heilshorn & Associates Life Sciences Virtual Conference. The webcast presentation will be available on Tuesday, December 15, 2009, at 8:00 a.m. Pacific time (11:00 a.m. Eastern time) by visiting the Company’s Web site at www.cytrx.com. The webcast presentation will be archived and available on the Web site for 90 days.
